Effective regulatory responses to predatory stem cell markets in Australia and Canada.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 39366360.
- Also identified by DOI 10.1016/j.stem.2024.09.007.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The rapid proliferation of businesses engaged in direct-to-consumer advertising of unproven stem cell interventions has raised troubling questions about whether government bodies can regulate this health market effectively. Recent developments in Australia and Canada suggest that such fears are unfounded and that targeted regulatory action can have meaningful effects.
Medical subject headings
- Stem Cells